References
Center for Cancer Control and Information Services of the National Cancer Center: ganjoho.jp. http://ganjoho.jp/reg_stat/index.html.
Jsffe ES. Introduction and over view of the classification of lymphoid neoplasms. In: Swerdlow SH, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2017. p. 190–8 (Textbook).
Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol Oncol. 2001;19(4):129–50.
Carbone PP, et al. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31(11):1860–1.
Cheson BD, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.
Rohatiner A, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400.
Shipp MA. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987–94 (3iA).
Zhou Z, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123(6):837–42 (3iA)..
Solal-Céligny P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104(5):1258–65 (3iA).
Hasenclever D, et al. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med. 1998;339(21):1506–14 (3iiiDiii).
Federico M, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555–62 (3iDiii).
Cheson BD, et al. Report of an International Workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol. 1999;17(4):1244–53.
Cheson BD, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–86.
Juweid ME, et al. Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop criteria (IWC) and 18F-fluorodeoxyglucose positron emission tomography (PET). J Clin Oncol. 2005;23(21):4652–61 (3iiiDiii).
Barrington SF, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048–58.
Weeks JC, et al. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol. 1991;9(7):1196–203 (3iiiD).
Oh YK, et al. Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies. Radiology. 1999;210(2):483–6 (3iiiD).
Liedtke M, et al. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol. 2006;17(6):909–13 (3iiiA).
Jerusalem G, et al. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease. Ann Oncol. 2003;14(1):123–30 (3iiiD).
Zinzani PL, et al. Role of fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol. 2009;27(11):1781–7 (3iiiD).
Hiniker SM, et al. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era. Int J Radiat Oncol Biol Phys. 2015;92(1):99–106.
Huntington SF, et al. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission. J Clin Oncol. 2015;33(13):1467–74.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Omachi, K. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma—overview. Int J Hematol 110, 3–10 (2019). https://doi.org/10.1007/s12185-019-02676-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-019-02676-0